Averin Capital is a venture capital firm investing at the intersection of breakthrough technology and human health. Based in New York, the firm backs founders building companies across foundational science, physical intelligence, care delivery, healthcare infrastructure, and human performance, with a focus on AI, robotics, programmable biology, advanced manufacturing, precision diagnostics, and advanced materials. The Averin team comprises operators, physicians, scientists, and healthcare executives who bring firsthand company-building experience—having collectively founded or launched over 30 companies and helped build 22 companies valued at $1B or more. The firm takes a hands-on approach, working closely with founders on product development, talent, partnerships, financing, and organizational scaling through every stage of growth.
Profile auto-generated from public sources — details unverified.